BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6195066)

  • 1. Influence of plasma proteinase inhibitors and aprotinin on trypsin-induced bradykinin release in vitro in man.
    Lasson A; Dittmann B; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1983 Sep; 364(9):1315-22. PubMed ID: 6195066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An in vitro study of the influence of plasma protease inhibitors and aprotinin on trypsin-induced C3 cleavage in human serum.
    Lasson A; Ohlsson K
    Biochim Biophys Acta; 1982 Dec; 709(2):227-33. PubMed ID: 6185150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of plasma protease inhibitors and Trasylol on trypsin-induced bradykinin-release in vitro and in vivo. Protease inhibitors and trypsin-induced bradykinin release.
    Balldin G; Gustafsson EL; Ohlsson K
    Eur Surg Res; 1980; 12(4):260-9. PubMed ID: 6166477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the human pancreatic secretory trypsin inhibitor on trypsin-induced C3 and kininogen cleavage: an in vitro study.
    Ohlsson K
    Scand J Gastroenterol Suppl; 1986; 126():18-20. PubMed ID: 2436281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trasylol prevents trypsin-induced shock in dogs.
    Balldin G; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1979 May; 360(5):651-6. PubMed ID: 89067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions in vitro and in vivo between anionic and cationic porcine trypsin and porcine plasma proteinase inhibitors.
    Hjelmqvist B; Borgström A; Ohlsson K
    Biol Chem Hoppe Seyler; 1988 Dec; 369(12):1331-6. PubMed ID: 3242553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
    Balldin G; Borgström A; Genell S; Ohlsson K
    Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypsin-induced release of bradykinin and of C3 fragments in man: clinical and experimental studies on the protective role of alpha 2-macroglobulin and aprotinin.
    Ohlsson F; Balldin G; Lasson A
    Adv Exp Med Biol; 1983; 156 (Pt B)():1083-90. PubMed ID: 6190382
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the influence of Trasylol on the partition of trypsin between the human plasma protease inhibitors in vitro.
    Balldin G; Ohlsson K; Olsson AS
    Hoppe Seylers Z Physiol Chem; 1978 Jun; 359(6):691-7. PubMed ID: 307526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
    Berling R; Borgström A; Ohlsson K
    Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the interaction of Trasylol (aprotinin) with trypsin-pancreatic secretory trypsin inhibitor (PSTI) complexes and with alpha 2-macroglobulin-trypsin-PSTI-complexes.
    Marks WH; Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1981 Dec; 362(12):1653-6. PubMed ID: 6172356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
    Lasson A
    Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The elimination in dogs of trypsin-alpha-macroglobulin complexes inactivated by the Kazal or the Kunitz inhibitor.
    Eddeland A; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1978 Mar; 359(3):379-84. PubMed ID: 76602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage of peptide hormones by alpha 2-macroglobulin-trypsin complex and its relation to the pathogenesis and chemotherapy of acute pancreatitis.
    Hermon-Taylor J; Magee AI; Grant DA; Jones PA; Marshall CE; Dunham J
    Clin Chim Acta; 1981 Jan; 109(2):203-9. PubMed ID: 6162593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute phase plasma proteins in kininogen-deficient Brown Norway rats.
    Damas J; Vranckx R; Adam A
    Arch Int Physiol Biochim; 1986 Jun; 94(2):173-8. PubMed ID: 2430537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of vascular permeability enhancement by human tryptase: dependence on activation of prekallikrein and direct release of bradykinin from kininogens.
    Imamura T; Dubin A; Moore W; Tanaka R; Travis J
    Lab Invest; 1996 May; 74(5):861-70. PubMed ID: 8642782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a possible role of the brain kallikrein-kinin system in the modulation of the cerebral circulation.
    Kamitani T; Little MH; Ellis EF
    Circ Res; 1985 Oct; 57(4):545-52. PubMed ID: 2412721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabexate mesilate (FOY) and aprotinin. A comparative study of the effects on trypsin-induced activation of the kinin and complement systems in vivo and in vitro.
    Lasson A; Balldin G; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1984 Dec; 365(12):1409-15. PubMed ID: 6084637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinin activation and protease inhibitors in acute pancreatitis in man.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1986; 198 Pt B():423-32. PubMed ID: 2433917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.